Coffee intake and coronary heart disease. 1994

M J Klag, and L A Mead, and A Z LaCroix, and N Y Wang, and J Coresh, and K Y Liang, and T A Pearson, and D M Levine
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore.

We examined the risk of coronary heart disease (CHD) associated with coffee intake in 1040 male medical students followed for 28 to 44 years. During the follow-up, CHD developed in 111 men. The relative risks (95% confidence interval) associated with drinking 5 cups of coffee/d were 2.94 (1.27, 6.81) for baseline, 5.52 (1.31, 23.18) for average, and 1.95 (0.86, 4.40) for most recent intake after adjustment for baseline age, serum cholesterol levels, calendar time, and the time-dependent covariates number of cigarettes, body mass index, and incident hypertension and diabetes. Risks were elevated in both smokers and nonsmokers and were stronger for myocardial infarction. Most of the excess risk was associated with coffee drinking prior to 1975. The diagnosis of hypertension was associated with a subsequent reduction in coffee intake. Negative results in some studies may be due to the assessment of coffee intake later in life or to differences in methods of coffee preparation between study populations or over calendar time.

UI MeSH Term Description Entries
D008297 Male Males
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003069 Coffee A beverage made from ground COFFEA beans (SEEDS) infused in hot water. It generally contains CAFFEINE and THEOPHYLLINE unless it is decaffeinated.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses

Related Publications

M J Klag, and L A Mead, and A Z LaCroix, and N Y Wang, and J Coresh, and K Y Liang, and T A Pearson, and D M Levine
September 1992, Archives of internal medicine,
M J Klag, and L A Mead, and A Z LaCroix, and N Y Wang, and J Coresh, and K Y Liang, and T A Pearson, and D M Levine
April 1993, Archives of internal medicine,
M J Klag, and L A Mead, and A Z LaCroix, and N Y Wang, and J Coresh, and K Y Liang, and T A Pearson, and D M Levine
January 2001, Heart, lung & circulation,
M J Klag, and L A Mead, and A Z LaCroix, and N Y Wang, and J Coresh, and K Y Liang, and T A Pearson, and D M Levine
September 2010, International journal of cardiology,
M J Klag, and L A Mead, and A Z LaCroix, and N Y Wang, and J Coresh, and K Y Liang, and T A Pearson, and D M Levine
June 1996, BMJ (Clinical research ed.),
M J Klag, and L A Mead, and A Z LaCroix, and N Y Wang, and J Coresh, and K Y Liang, and T A Pearson, and D M Levine
November 2007, Current opinion in clinical nutrition and metabolic care,
M J Klag, and L A Mead, and A Z LaCroix, and N Y Wang, and J Coresh, and K Y Liang, and T A Pearson, and D M Levine
February 2007, Current opinion in lipidology,
M J Klag, and L A Mead, and A Z LaCroix, and N Y Wang, and J Coresh, and K Y Liang, and T A Pearson, and D M Levine
March 1994, Epidemiology (Cambridge, Mass.),
M J Klag, and L A Mead, and A Z LaCroix, and N Y Wang, and J Coresh, and K Y Liang, and T A Pearson, and D M Levine
February 1995, Current opinion in lipidology,
M J Klag, and L A Mead, and A Z LaCroix, and N Y Wang, and J Coresh, and K Y Liang, and T A Pearson, and D M Levine
April 1991, BMJ (Clinical research ed.),
Copied contents to your clipboard!